690 results for "krytan tek side effects"

Search for:

Date Range to

690 Results on GlaucomaToday.com

December 2017December 2017

A Fond Fairwell By Steven D. Vold, MD

The Literature By Jing Wang, MD, FRCSC, and Chelvin Sng, MBBChir, FRCEd

IOP-Reducing “Electroceutical” Eyeglasses Are Generating Buzz A novel device, in early development, relies on electronic stimulation to decrease IOP.
By Rochelle Nataloni, Senior Writer

Deep Impact How being diagnosed with glaucoma and coping with the disease affect patients’ quality of life.
By Geoffrey T. Emerick, MD

Lifestyle Recommendations What advice can we give?
By Cynthia Mattox, MD

There Is More to Satisfying Patients Than Reducing IOP An artfully executed clinic experience shows patients you care.
By John Berdahl, MD

Patients’ Treatment Preferences For most patients, starting an eye drop is the simplest first step.
By Atalie C. Thompson, MD, MPH, and Kelly W. Muir, MD, MHS

Attention to Prevention Opportunities to increase glaucoma awareness and enhance early detection.
By Constance O. Okeke, MD, MSCE

As Vision Dims Current perspectives on managing glaucoma patients with low vision rehabilitation.
By Kara Hanson, OD, FAAO

Industry News

October 2017October 2017

The Literature By Nisha Chadha, MD, and Timothy P. Fox, MD

You Say You Want a Revolution Antivascular endothelial growth factor agents have dramatically changed the early management of neovascular glaucoma.
By Mark Slabaugh, MD, and Matthew Ohr, MD

A Lesson Learned on Patient Selection Patchless glaucoma tube shunts can result in great outcomes—for the right patients.
By Constance O. Okeke, MD, MSCE

Implants and Injectables An overview of devices in development.
By Inder Paul Singh, MD

Getting in the Ring Could an external drug delivery device help knock out noncompliance?
By Brian Flowers, MD

Novel Addition for IOP Reduction Rho kinase inhibitors could shake up glaucoma medical therapy.
By Janet B. Serle, MD

Nitric Oxide: a Therapeutic Target for Glaucoma Latanoprostene bunod shows promise.
By Carla J. Siegfried, MD

Compounded Glaucoma Medications Could this therapeutic strategy solve some problems?
By Lauren Seo and Nathan Radcliffe, MD

Help for Dry Eyes Treating ocular surface disease in glaucoma patients.
By Francis W. Price Jr, MD

August 2017August 2017

The Literature By Elizabeth D. Marlow, MD; Paul Petrakos, DO; and Charles Cole, MD

Dispatch From the Cutting Edge Researchers reported on new drugs, diagnostics, and devices at the 2017 ARVO Annual Meeting.
By Kunjal K. Modi, MD, and Albert S. Khouri, MD

A Two-Pronged Approach Using retinal photography and perimetry to diagnose glaucoma.
By Murray Fingeret, OD, and Richard A. Lewis, MD

Future Shock The current proliferation of new options for the surgical management of glaucoma may be just the beginning.
By Jonathan S. Myers, MD

The Problem With Oil By James Lin, MD

Show Me the Money Coding tips for teleglaucoma.
By April Maa, MD

News and Innovations

June 2017June 2017

Surgical Management of Traumatic Glaucoma A stepwise approach.
By Omolola O. Idowu, MBChB, MRCS(Ed), and Carla I. Bourne, MD

My First Subconjunctival MIGS Cases The learning curve, the snags, and the overall experience of adopting a new procedure.
By Inder Paul Singh, MD

A Balancing Act Managing advanced, uncontrolled glaucoma in the elderly can present unique challenges.
By Michael C. Stiles, MD

Moving Beyond IOP Can OCT-A aid glaucoma diagnosis and management?
By Kunjal K. Modi, MD, and Albert S. Khouri, MD

Dispatch From Down Under The state of glaucoma care in Australia.
By Michael Coote, MB, BS, FRANZCO, GAICD

Promoting Diversity The National Medical Association works to reduce racial and ethnic disparities in medicine.
By Mildred M. G. Olivier, MD

Managing Glaucoma in the Patient With Herpetic Disease Success requires treating the underlying disorder, inflammation, and elevated IOP.
By Adam Breunig, MD, and Steven V. L. Brown, MD

Inflammatory Glaucomas Advice on their detection and treatment.
By Lily Im, MD

Beware the Impostor Differentiating glaucoma from anterior ischemic optic neuropathy.
By Siddarth Rathi, MD, MBA, and David S. Greenfield, MD

Isarna Presents Positive Clinical Data for ISTH0036

April 2017April 2017

The Literature By Darrell WuDunn, MD, PhD, and Joshua W. Evans, MD

Highlights of the AGS Annual Meeting The latest results of clinical trials and research studies presented at the 27th Annual Meeting of the American Glaucoma Society, held March 2 to 5, 2017, in Coronado, California.
By Ambika Hoguet, MD, and Lucy Q. Shen, MD

Where We Are Today With MIGS With Leon W. Herndon, MD; Oluwatosin U. Smith, MD; Mahmoud A. Khaimi, MD; Sameh Mosaed, MD; Michael D. Greenwood, MD; Steven R. Sarkisian Jr, MD; Michael Berlin, MD, MS; Vigan Roka, MD; Michael Riggs; and Ulrich Giers, MD; Steven D. Vold, MD; Marc Töteberg-Harms, MD, FEBO; Erik L. Mertens, MD, FEBOphth, and Howard Barnebey, MD

Research Update on Laser Trabeculoplasty A literature search reveals interesting findings from 2016.
By Tony Realini, MD, MPH

123456789101112131415161718 | Next >